UK MHRA Draws Up A Roadmap Of Patient Protection And Rapid Science Uptake

05 Jul 2021

The UK's health care products regulator wants to capitalize on its post-EU, standalone status by setting an agenda for change that protects public health through excellence in regulation and science.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has released a two-year Delivery Plan 2021-2023 that sets a new long-term business model and lays the ground to build an organization that can match and adapt rapidly to future needs in patient safety and regulating for innovation.

The roadmap, released on 4 July, is an attempt to maximize the opportunities that the UK’s post-EU status present. The...